Thanks for that Beaza. Once again Rennie just
can’t resist misleading (exaggerating) the potential
revenue for PAR from the sales of Zilosul. If the
drug does achieve 5% penetration of the US
market, then TOTAL sales may be somewhere
around the $5B mark. However PAR’s share may
be as low as 10% royalty of that figure. Now
$500M is still a pretty handsome figure, if you
take where we are today, so why can’t he be
totally honest with his audience?
Thanks for that Beaza. Once again Rennie justcan’t resist...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 23.0¢ | $92.58K | 388.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171112 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 34125 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |